These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36910351)

  • 1. Assessment of electrolytes, markers of glycaemic control and renal dysfunction among adult Nigerians recently diagnosed with type 2 diabetes mellitus.
    Ekun OA; Fagbemi OF; Adejumo EN; Ekun OO; Wojuade KS; Oshundun FM; Adefolaju FO; Oyegbami SR
    Afr Health Sci; 2022 Sep; 22(3):296-306. PubMed ID: 36910351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarker for cardiorenal syndrome risk in patients with liver cirrhosis and type 2 diabetes in Saudi Arabia.
    Mohammedsaeed W; Alghamdi ZJ
    Saudi Med J; 2024 Jul; 45(7):675-684. PubMed ID: 38955454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The predictive value of serum mannan-binding lectin levels for diabetic control and renal complications in type 2 diabetic patients.
    Elawa G; AoudAllah AM; Hasaneen AE; El-Hammady AM
    Saudi Med J; 2011 Aug; 32(8):784-90. PubMed ID: 21858386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is serum C-reactive protein concentration correlated with HbA1c and insulin resistance in Type 2 diabetic men with or without coronary heart disease?
    Bahceci M; Tuzcu A; Ogun C; Canoruc N; Iltimur K; Aslan C
    J Endocrinol Invest; 2005 Feb; 28(2):145-50. PubMed ID: 15887860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The possible correlation between serum GRB2 levels and carotid atherosclerosis in patients with type 2 diabetes mellitus.
    Dong Y; Liu J; Ma J; Quan J; Bao Y; Cui Y
    Front Endocrinol (Lausanne); 2022; 13():963191. PubMed ID: 36176460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between High-Sensitivity C-Reactive Protein and Diabetic Kidney Disease in Patients With Type 2 Diabetes Mellitus.
    Tang M; Cao H; Wei XH; Zhen Q; Liu F; Wang YF; Fan NG; Peng YD
    Front Endocrinol (Lausanne); 2022; 13():885516. PubMed ID: 35784528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid dysfunction and glycaemic control among Type 2 diabetes mellitus patients in Ghana: A comparative cross-sectional study.
    Sakyi SA; Ameyaw B; Laing EF; Anthony R; Ephraim RKD; Effah A; Kwayie AA; Senu E; Anto EO; Acheampong E; Afranie BO; Amoani B; Opoku S
    Endocrinol Diabetes Metab; 2023 Nov; 6(6):e447. PubMed ID: 37621219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for diabetic nephropathy complications in community patients with type 2 diabetes mellitus in Shanghai: Logistic regression and classification tree model analysis.
    Lou J; Jing L; Yang H; Qin F; Long W; Shi R
    Int J Health Plann Manage; 2019 Jul; 34(3):1013-1024. PubMed ID: 31368138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of serum glycated albumin and high-sensitivity C-reactive protein levels in the prediction of presence of coronary artery disease in patients with type 2 diabetes.
    Pu LJ; Lu L; Xu XW; Zhang RY; Zhang Q; Zhang JS; Hu J; Yang ZK; Ding FH; Chen QJ; Lou S; Shen J; Fang DH; Shen WF
    Cardiovasc Diabetol; 2006 Dec; 5():27. PubMed ID: 17178005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluctuation between fasting and 2-H postload glucose state is associated with glomerular hyperfiltration in newly diagnosed diabetes patients with HbA1c < 7%.
    Hou X; Wang C; Wang S; Yang W; Ma Z; Wang Y; Li C; Li M; Zhang X; Zhao X; Sun Y; Song J; Lin P; Liang K; Gong L; Wang M; Liu F; Li W; Yan F; Yang J; Wang L; Tian M; Liu J; Zhao R; Chen S; Chen L
    PLoS One; 2014; 9(10):e111173. PubMed ID: 25360521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of interleukin-2 and interleukin-18 in newly diagnosed type 2 diabetes mellitus.
    Suri S; Mitra P; Abhilasha A; Saxena I; Garg MK; Bohra GK; Sharma P
    J Basic Clin Physiol Pharmacol; 2021 Mar; 33(2):185-190. PubMed ID: 33711216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poor glycemic control and decreased renal function are associated with increased intrarenal RAS activity in Type 2 diabetes mellitus.
    Nakatani S; Ishimura E; Naganuma T; Nakatani A; Ichii M; Fukumoto S; Mori K; Emoto M; Nakatani T; Inaba M
    Diabetes Res Clin Pract; 2014 Jul; 105(1):40-6. PubMed ID: 24846444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycemic control, dyslipidemia and endothelial dysfunction in coexisted diabetes, hypertension and nephropathy.
    Shahid SM; Nawab SN; Shaikh R; Mahboob T
    Pak J Pharm Sci; 2012 Jan; 25(1):123-9. PubMed ID: 22186319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excessive visit-to-visit glycemic variability independently deteriorates the progression of endothelial and renal dysfunction in patients with type 2 diabetes mellitus.
    Wei F; Sun X; Zhao Y; Zhang H; Diao Y; Liu Z
    BMC Nephrol; 2016 Jul; 17(1):67. PubMed ID: 27386849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 12-week moderate aerobic exercise on ROCK2 activity, hs-CRP and glycemic index in obese patients with impaired glucose tolerance.
    Kargarfard M; Nobari H; Kamyar K; Zadeh AK; Oliveira R
    Physiol Behav; 2022 Dec; 257():113976. PubMed ID: 36183850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uric acid as a link between renal dysfunction and both pro-inflammatory and prothrombotic state in patients with metabolic syndrome and coronary artery disease.
    Zapolski T; Waciński P; Kondracki B; Rychta E; Buraczyńska MJ; Wysokiński A
    Kardiol Pol; 2011; 69(4):319-26. PubMed ID: 21523662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between dyslipidaemia and glycaemic status in patients with Type 2 diabetes mellitus.
    Thambiah SC; Samsudin IN; George E; Zahari Sham SY; Lee HM; Muhamad MA; Hussei Z; Mohd Noor N; Mohamad M
    Malays J Pathol; 2016 Aug; 38(2):123-30. PubMed ID: 27568669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between inflammatory markers, traditional risk factors, and complications in patients with type 2 diabetes mellitus.
    Streja D; Cressey P; Rabkin SW
    J Diabetes Complications; 2003; 17(3):120-7. PubMed ID: 12738395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of glycated haemoglobin (HbA1
    Mustafa IO; Tanko Y; Yusuf R; Musa SA
    Diabetes Metab Syndr; 2019; 13(5):2967-2972. PubMed ID: 31437811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of inflammatory markers (high-sensitivity C-reactive protein, nuclear factor-κB, and adiponectin) in Indian patients with type 2 diabetes mellitus with and without macrovascular complications.
    Misra DP; Das S; Sahu PK
    Metab Syndr Relat Disord; 2012 Jun; 10(3):209-13. PubMed ID: 22316266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.